Loading...
OTCM
POSC
Market cap24mUSD
Jul 09, Last price  
1.71USD
1D
-2.29%
1Q
-9.04%
Jan 2017
8,450.00%
Name

Positron Corp

Chart & Performance

D1W1MN
OTCM:POSC chart
P/E
—
P/S
52.90
EPS
—
Div Yield, %
—
Shrs. gr., 5y
22.99%
Rev. gr., 5y
-10.94%
Revenues
461k
-21.45%
5,068,0002,780,000762,0002,213,0003,309,0002,126,0001,446,0004,623,0006,663,0002,801,0001,630,0001,466,0001,445,857777,957823,745881,951727,583734,666587,500461,452
Net income
-11m
L+344.01%
892,000-1,658,000-3,806,000-6,586,000-7,780,000-8,975,000-5,749,000-10,923,000-6,121,000-7,955,000-7,104,000-2,584,00012,555-20,752-62,071-595,075-2,859,007-1,638,703-2,388,091-10,603,392
CFO
-5m
L+171.56%
-74,000-1,293,000-2,208,000-1,613,000-3,500,000-3,407,000-3,345,000-4,687,000-4,075,000-2,240,000-3,046,000-2,415,00095,643-2,568-104,995-616,286-2,542,755-1,595,683-1,730,862-4,700,299

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Positron Corporation is a healthcare firm specializing in nuclear medicine, with a core emphasis on cardiac Positron Emission Tomography (PET) imaging services throughout the United States. The company empowers healthcare providers by offering its proprietary Attrius PET scanner, comprehensive clinical and technical support, and flexible financing solutions. These integrated offerings enable medical professionals to precisely diagnose heart conditions, enhance patient health outcomes, and deliver medical care with greater cost-efficiency. Positron Corporation was founded in 1983 and operates from its headquarters in Niagara Falls, New York.
URL
https://www.positron.com/
IPO date
Feb 10, 1994
Employees
19
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT